CounterAct
- Product NDC
- 54473-305
- 11-digit product format
- 544730305
- Labeler code
- 54473
- Product ID
- 54473-305_30ce656f-cab7-9520-e063-6294a90a43ff
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Melaleuca, Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2016-05-02
- Substance
- ACETAMINOPHEN
- Active strength
- 500 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 54473-305-50 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 54473-305-50 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 54473-305-50 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 54473-305-50 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 54473-305-50 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 54473-305-50 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 54473-305-50 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- CounterAct
- Brand name suffix
- Pain
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 54473-305-50 | 2025-03-21 | C162847 | 48780-1 | 2cef2736-aae7-d83d-e063-dadaa90ab31f | CounterAct Pain Content of Labeling |
| 54473-305-50 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-aae7-d83d-e063-dadaa90ab31f | CounterAct Pain Content of Labeling |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54473-305-50 | CounterActPain | 50 in 1 BOTTLE | TABLET, FILM COATED | 50 | 3 | |
| 54473-305-50 | CounterActPain | 1 in 1 BOX | TABLET, FILM COATED | 1 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Extra Strength Acetaminophen | ACETAMINOPHEN | NuCare Pharmaceuticals, Inc. | 41affa1a-5aac-7fc0-e063-6394a90a5557 | 2025-10-30 | Warnings | M013 |
| MAPAP Extra Strength | ACETAMINOPHEN | Major Pharmaceuticals | 34a95450-3f04-4de4-9113-73e7bd5724a0 | 2025-10-29 | Warnings | M013 |
| GOODNOW PAIN RELIEF | ACETAMINOPHEN | Gobrands, Inc | 4d4a78a5-5a88-4f24-b685-c7c6bb5e989e | 2025-10-29 | Warnings | M013 |
| Sanaflu Xtra | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | GRANDALL DISTRIBUTING, LLC | 4af8a566-5251-4d46-8692-87a3a0748334 | 2025-10-28 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Rising Pharma Holdings, Inc. | f8237772-7656-49fb-b1de-f8fcb5fa55ee | 2025-10-28 | Warnings | M013 |
| DG Health Pain Relief | ACETAMINOPHEN | Dolgencorp Inc | 42f0c87c-7020-4af7-9f6b-3a774137e564 | 2025-10-24 | Warnings | M013 |
| GOODYS Hangover | ASPIRIN AND CAFFEINE | Medtech Products Inc. | 0b0067e0-58b0-4581-aa4b-e398c32c559a | 2025-10-23 | Warnings | M013 |
| GOODYS Extra Strength Headache Mixed Fruit Blast | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Medtech Products Inc. | 6cb758bf-5a50-46bb-96e7-65b810b12de0 | 2025-10-23 | Warnings | M013 |
| Nyt Time Sleep Caps | DIPHENHYDRAMINE HYDROCHLORIDE | DISCOUNT DRUG MART | e3f4d063-921d-4503-89a6-26cc9c46b4c9 | 2025-10-23 | Warnings | M013 |
| Anacin | ASPRIN AND CAFFEINE | Insight Pharmaceuticals LLC | 51ab0ee3-3c94-424d-a30a-2d6c14e3d8ff | 2025-10-23 | Warnings | M013 |
| Goodys Back and Body Pain | ACETAMINOPHEN AND ASPRIN | Medtech Products Inc. | 055d0288-61d4-48bc-b91f-6ecc1969beb8 | 2025-10-23 | Warnings | M013 |
| Goodys Cool Orange Headache | ACETAMINOPHEN AND ASPIRIN AND CAFFEINE | Medtech Products Inc. | 31212c97-9975-427e-bc3d-f7125f30299a | 2025-10-23 | Warnings | M013 |
| BC Arthritis | ASPIRIN AND CAFFEINE | Medtech Products Inc. | 3a85be2d-6548-4de5-8109-60e1ca2bfca3 | 2025-10-23 | Warnings | M013 |
| Goodys Extra Strength | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Medtech Products Inc. | d4325b17-23bc-44ac-868d-bb0886853a73 | 2025-10-23 | Warnings | M013 |
| BC | ASPIRIN AND CAFFEINE | Medtech Products Inc. | 226173d4-b6d5-4fe6-b24e-1cc5d1b31c88 | 2025-10-23 | Warnings | M013 |
| BC MAX | ASPIRIN, ACETAMINOPHEN, CAFFEINE | Medtech Products Inc. | 1e2a07ab-23e6-49b4-a676-212dc6880f14 | 2025-10-23 | Warnings | M013 |
| Ecotrin Regular Strength | ASPIRIN | Medtech Products Inc. | 36cb530b-25b2-4f62-a25d-aa04360815a8 | 2025-10-23 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Rugby Laboratories | b16ed4ef-689c-4df2-ab6c-207aa8b9925d | 2025-10-22 | Warnings | M013 |
| Tension Headache Relief | ACETAMINOPHEN, CAFFEINE | TIME CAP LABS INC | 05364eb4-07a1-a4d9-e063-6294a90a47e5 | 2025-10-21 | Warnings | M013 |
| Acetaminophen, Aspirin, Caffeine | ACETAMINOPHEN, ASPIRIN, CAFFEINE | CVS Pharmacy, Inc. | 6deb854f-863e-24ad-e053-2991aa0afb17 | 2025-10-21 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 198440 | acetaminophen 500 MG Oral Tablet | PSN | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 1100005 | CounterAct Pain 500 MG Oral Tablet | PSN | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 1100005 | acetaminophen 500 MG Oral Tablet [CounterAct Pain] | SBD | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 198440 | acetaminophen 500 MG Oral Tablet | SCD | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 198440 | APAP 500 MG Oral Tablet | SY | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 1100005 | APAP 500 MG Oral Tablet [CounterAct Pain] | SY | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
| 1100005 | CounterAct Pain 500 MG Oral Tablet | SY | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 54473-305-50 | 54473030550 | 1 BOTTLE in 1 BOX (54473-305-50) / 50 TABLET, FILM COATED in 1 BOTTLE | 1 bottle | 2018-01-01 | 0000-00-00 | No | No | Current |